J&J Visions’ Acuvue Theravision with Ketotifen Receives MHLW’s Approval for Vision Correction and Allergic Eye Itch

March 25, 2021 Auto Bot approval, Johnson & Johnson, MHLW, patients, receives, regulatory 0

Shots:

  • The MHLW has approved Acuvue Theravision with Ketotifen as the first combination contact lens that provides vision correction and an antihistamine drug to relieve symptoms for people experiencing itchy allergy eyes
  • Data demonstrated that 8 out of 10 contact lens wearers feel frustrated when their eye allergies interfere with normal contact lens wear. The products may help patients to wear contact lenses during the allergy season
  • Acuvue Theravision with Ketotifen marks the first regulatory approval by any health authority while the company is working with authorities globally to bring novel technology to lens wearer

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Drug Dangers

The post J&J Visions’ Acuvue Theravision with Ketotifen Receives MHLW’s Approval for Vision Correction and Allergic Eye Itch first appeared on PharmaShots.